The country's second largest drug firm Cipla has been in favour of alliances to grow its footprint. It has joined hands with the world's largest generic company Teva to sell its products in certain markets. This alliance could turn out to be the most critical for Cipla, reports CNBC-TV18
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
